Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome

Vascular Medicine
Ami B BhattMark A Creager

Abstract

We conducted a randomized, double-blind trial of losartan (100 mg QD) versus atenolol (50 mg QD) for 6 months in adults with Marfan syndrome. Carotid-femoral pulse wave velocity (PWV), central augmentation index (AIx), aortic diameter and left ventricular (LV) function were assessed with arterial tonometry and echocardiography. Thirty-four subjects (18 female; median age 35 years, IQR 27, 45) were randomized. Central systolic and diastolic blood pressure decreased comparably with atenolol and losartan (p = 0.64 and 0.31, respectively); heart rate decreased with atenolol (p = 0.02), but not with losartan. PWV decreased in patients treated with atenolol (-1.15 ± 1.68 m/s; p = 0.01), but not in those treated with losartan (-0.22 ± 0.59 m/s; p = 0.15; between-group difference p = 0.04). In contrast, AIx decreased in the losartan group (-9.6 ± 8.6%; p < 0.001) but not in the atenolol group (0.9 ± 6.2%, p = 0.57; between-group difference p < 0.001). There was no significant change in aortic diameters or LV ejection fraction in either treatment group. In adults with Marfan syndrome, 6 months of treatment with atenolol improves PWV, whereas losartan reduces the AIx. By improving vascular stiffness via distinct mechanisms of action, the...Continue Reading

References

Dec 1, 1991·European Heart Journal·G SütschM Turina
Jul 1, 1991·Journal of the American College of Cardiology·K HirataH Boudoulas
Apr 15, 1985·The American Journal of Cardiology·W W NicholsC R Conti
Apr 13, 1972·The New England Journal of Medicine·J L MurdochV A McKusick
Sep 15, 1994·The American Journal of Cardiology·M A SalimR E Pyeritz
Aug 15, 1994·The American Journal of Cardiology·R W JeremyJ G Richards
Nov 1, 1993·Journal of the American College of Cardiology·M J RomanR B Devereux
Apr 24, 1996·American Journal of Medical Genetics·A De PaepeR E Pyeritz
Jan 1, 1997·American Heart Journal·A HaouziR J Siegel
Feb 5, 2002·American Journal of Hypertension·Ian B WilkinsonJohn R Cockcroft
Jun 8, 2002·Hypertension·Pierre LantelmeHugues Milon
Dec 4, 2002·American Journal of Hypertension·Azra Mahmud, John Feely
Feb 25, 2003·Nature Genetics·Enid R NeptuneHarry C Dietz
Jan 31, 2004·American Journal of Hypertension·Trefor MorganAdrianne Anderson
Jul 3, 2004·European Heart Journal·Gijs J NollenBarbara J M Mulder
Jul 31, 2004·Nature Genetics·Rosemary J Akhurst
Dec 1, 2005·International Journal of Cardiology·Julie F De BackerJohan De Sutter
Feb 2, 2006·American Journal of Hypertension·Zahid DhakamIan B Wilkinson
Feb 8, 2006·The American Journal of Cardiology·Antonio VitarelliFiorella Caranci
Sep 27, 2006·European Heart Journal·Stephane LaurentUNKNOWN European Network for Non-invasive Investigation of Large Arteries
Jan 11, 2007·Journal of Hypertension·Masato SakuraiMasaaki Ito
Jan 31, 2007·The American Journal of Cardiology·Magalie LadouceurGuillaume Jondeau
Jan 31, 2007·Clinical Cardiology·Meike RybczynskiYskert von Kodolitsch
Oct 4, 2007·JAMA : the Journal of the American Medical Association·Anna A AhimastosBronwyn A Kingwell
Oct 25, 2007·Journal of Cardiothoracic Surgery·Rupert A PayneMartin A Denvir
Jan 15, 2008·Journal of Hypertension·Zahid DhakamIan B Wilkinson
Jan 16, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Markus KoschMartin Hausberg
Apr 26, 2008·American Journal of Hypertension·Azra Mahmud, John Feely
Jun 27, 2008·The New England Journal of Medicine·Benjamin S BrookeHarry C Dietz
Oct 2, 2009·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Anatoli KiotsekoglouAnne H Child
Dec 10, 2009·Hypertension·Scott D SolomonUNKNOWN Exforge Intensive Control of Hypertension to Evaluate Efficacy in Diastolic Dysfunction Investigators

❮ Previous
Next ❯

Citations

Jan 3, 2016·The Canadian Journal of Cardiology·Michael N Singh, Ronald V Lacro
Nov 26, 2015·European Journal of Medical Genetics·Elyssa CannaertsBart Loeys
Feb 27, 2016·Human Mutation·Aline VerstraetenBart Loeys
Oct 28, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Yohei AkazawaYuji Inaba
Jan 20, 2017·Nature Reviews. Cardiology·Aline VerstraetenBart Loeys
Nov 8, 2017·The Cochrane Database of Systematic Reviews·Hyun-Kyoung KooVijaya M Musini
Aug 14, 2019·Journal of Cellular and Molecular Medicine·Fabian EmrichMichael P Fischbein
Jul 2, 2019·European Journal of Preventive Cardiology·Lin LiMuhammad Shariq Usman
Mar 23, 2021·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Duygu KocyigitBo Xu
Apr 21, 2019·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yi-No KangHsin-Hui Chiu

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Clinical Trials Mentioned

NCT00723801

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Cardiac Aneurysm

Aneurysm refers to a bulge of the wall or lining of a vessel commonly occurring in the blood vessels at the base of the septum or within the aorta. In the heart, it usually arises from a patch of weakened tissue in a ventricular wall, which swells into a bubble filled with blood. Discover the latest research on cardiac aneurysm here.